| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Revolution Medicines, Inc. (RVMD) has 13 insiders with recent SEC Form 4 filings, including 2 buys and 13 sells. RVMD is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| ? | 2.34M | $381.21M | - | |
| Other | 278.6K | $45.41M | - | |
| Other | 232.5K | $37.89M | - | |
| COO | 119.9K | $19.54M | - | |
| ? | 96.6K | $15.74M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 16, 2024 | Horn Margaret A48 | Chief Operating Officer | Sell | 4,329 | $45.40 | $196,553.05 | -3.3% | -12.5% | +73.5% | |
| Dec 16, 2024 | Goldsmith Mark A52 | See Remarks | Sell | 11,714 | $45.40 | $531,860.11 | -3.5% | -12.5% | +73.5% | |
| Dec 16, 2024 | Kelsey Stephen Michael46 | See Remarks | Sell | 4,663 | $45.40 | $211,717.92 | -1.8% | -12.5% | +73.5% | |
| Dec 16, 2024 | Cislini Jeff | General Counsel | Sell | 1,599 | $45.40 | $72,600.68 | -3.7% | -12.5% | +73.5% | |
| Dec 16, 2024 | Anders Jack47 | Chief Financial Officer | Sell | 2,635 | $45.40 | $119,639.01 | -2.7% | -12.5% | +73.5% | |
| Dec 5, 2024 | Schroeder Thilo80 | Director | Buy | 1,304,347 | $46.00 | $59,999,962.00 | +84.0% | -16.2% | +68.4% | |
| Nov 15, 2024 | Cislini Jeff | General Counsel | Sell | 2,554 | $55.13 | $140,811.47 | -5.6% | -25.0% | +22.9% | |
| Nov 13, 2024 | Kelsey Stephen Michael46 | See Remarks | Sale+OE | 16,666 | $58.65 | $977,508.80 | -3.0% | -28.7% | +10.8% | |
| Nov 6, 2024 | Cislini Jeff | General Counsel | Sale+OE | 6,000 | $60.00 | $360,000.00 | -11.6% | -28.8% | +3.3% | |
| Nov 4, 2024 | Goldsmith Mark A52 | See Remarks | Sale+OE | 70,000 | $55.41 | $3,878,773.11 | -9.8% | -24.6% | +4.8% |